# Smith & Nephew to acquire Ceterix Orthopaedics for up to $105M

Smith & Nephew agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device for up to $105 million, including $50 million upfront and $55 million in earn-outs.

- Type: Acquisition
- Announced: 2018-12-18
- Where: Fremont, California, United States
- Value: $105.0M
- Status: announced
- Products: NovoStitch Pro knee repair device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Smith & Nephew](https://endata.com/companies/19873.md) (acquirer)
- [Ceterix Orthopaedics](https://endata.com/companies/36257.md) (target)
- [Ceterix](https://endata.com/companies/37285.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/smith-nephew-to-pay-up-to-105m-for-ceterix-orthopaedics/), 2018-12-18: "Smith & Nephew today announces that it has agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device."
- [hulldailymail.co.uk](https://www.hulldailymail.co.uk/news/business/smith--nephew-spend-up-2390541), 2019-01-04: "Smith & Nephew has agreed to buy an American medical technology firm in a deal which could rise to more than £80m."
- [thehealthcaretechnologyreport.com](https://thehealthcaretechnologyreport.com/smith-nephew-acquires-ceterix-for-potential-105m/), 2019-02-13: "We are excited by the growth opportunities of the NovoStitch Pro at Smith & Nephew and are proud of the impact our technology has made in developing the meniscal repair market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.